Neurocrine Biosciences: Q1 Earnings Insights

Neurocrine Biosciences NBIX reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Neurocrine Biosciences missed estimated earnings by 11.76%, reporting an EPS of $0.3 versus an estimate of $0.34.

Revenue was up $74.00 million from the same period last year.

Last quarter the company missed on EPS by $0.48 which was followed by a 7.45% increase in the share price the next day.

Here's a look at Neurocrine Biosciences's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	0.52	0.60	0.49	0.51
EPS Actual	0.04	0.64	0.63	0.49
Revenue Estimate	316.79M	297.65M	274.38M	250.63M
Revenue Actual	312.00M	296.00M	288.90M	236.60M

To track all earnings releases for Neurocrine Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar